Overview

Pharmacodynamics, Safety and Efficacy of Topical Omiganan in Patients With External Genital Warts

Status:
Completed
Trial end date:
2017-03-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the pharmacodynamics, safety and efficacy of omiganan in patients with external genital warts.
Phase:
Phase 2
Details
Lead Sponsor:
Cutanea Life Sciences, Inc.
Maruho Co., Ltd.
Collaborator:
Leiden University Medical Center